Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

Hiroyuki Mano and colleagues report fusions involving DUX4 in 16.4% of Ph-negative adolescent and young adult acute lymphoblastic leukemia (AYA-ALL) cases. Transplantation assays in mice support an oncogenic role for the DUX4-IGH fusion gene, which expresses DUX4 protein with an aberrant C terminus...

Full description

Saved in:
Bibliographic Details
Published in:Nature genetics Vol. 48; no. 5; pp. 569 - 574
Main Authors: Yasuda, Takahiko, Tsuzuki, Shinobu, Kawazu, Masahito, Hayakawa, Fumihiko, Kojima, Shinya, Ueno, Toshihide, Imoto, Naoto, Kohsaka, Shinji, Kunita, Akiko, Doi, Koichiro, Sakura, Toru, Yujiri, Toshiaki, Kondo, Eisei, Fujimaki, Katsumichi, Ueda, Yasunori, Aoyama, Yasutaka, Ohtake, Shigeki, Takita, Junko, Sai, Eirin, Taniwaki, Masafumi, Kurokawa, Mineo, Morishita, Shinichi, Fukayama, Masashi, Kiyoi, Hitoshi, Miyazaki, Yasushi, Naoe, Tomoki, Mano, Hiroyuki
Format: Journal Article
Language:English
Published: New York Nature Publishing Group US 01-05-2016
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hiroyuki Mano and colleagues report fusions involving DUX4 in 16.4% of Ph-negative adolescent and young adult acute lymphoblastic leukemia (AYA-ALL) cases. Transplantation assays in mice support an oncogenic role for the DUX4-IGH fusion gene, which expresses DUX4 protein with an aberrant C terminus at high levels in patients with AYA-ALL. The oncogenic mechanisms underlying acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA; 15–39 years old) remain largely elusive 1 , 2 , 3 . Here we have searched for new oncogenes in AYA-ALL by performing RNA-seq analysis of Philadelphia chromosome (Ph)-negative AYA-ALL specimens ( n = 73) with the use of a next-generation sequencer. Interestingly, insertion of D4Z4 repeats containing the DUX4 gene into the IGH locus was frequently identified in B cell AYA-ALL, leading to a high level of expression of DUX4 protein with an aberrant C terminus. A transplantation assay in mice demonstrated that expression of DUX4 - IGH in pro-B cells was capable of generating B cell leukemia in vivo . DUX4 fusions were preferentially detected in the AYA generation. Our data thus show that DUX4 can become an oncogenic driver as a result of somatic chromosomal rearrangements and that AYA-ALL may be a clinical entity distinct from ALL at other ages.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1061-4036
1546-1718
DOI:10.1038/ng.3535